Skip to content
Screener

Exelixis EXEL Other Income (Expense)

Other Income (Expense) at other companies

Eli Lilly logo
Eli LillyLLY
$269M+399%
Kura Oncology logo
Kura OncologyKURA
$5.49M-26.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$3.26M+21.1%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$5M-37.5%
Opko Health logo
Opko HealthOPK
-$6.43M+93.7%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$3.9M-160%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses380,276354,685739,747723,273
Income from operations248,414213,576499,755400,435
Interest income14,21016,78930,33735,865
Other income (expenses), net5450273(195)
Income before income taxes262,678230,415530,365436,105
Provision for income taxes50,62845,567107,84891,641
Net income$212,050$184,848$422,517$344,464
Net income per share:

Item 1. Financial Statements.

FAQ

What is Exelixis's other income (expense)?
Exelixis (EXEL) reported other income (expense) of $54K in Q2 2026.
How has Exelixis's other income (expense) changed year-over-year?
Exelixis's other income (expense) increased by 8.0% year-over-year, from $50K to $54K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Exelixis's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude